Allergy and Immunology · Hershey, PA
NPI
1295155885
Since 2014
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 University Drive Mc A410
Hershey, PA, 17033
Phone (800) 243-1455
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,067
276 services
Medicare patients, 2024
90
Average age 67
Drug cost, 2024
$4.5M
552 prescriptions
Company payments, 2025
$19.45
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Taha Al-Shaikhly was code 99213 (office e&m - established), 27 times for 26 patients. In total Taha Al-Shaikhly billed 276 services in 18 codes, and Medicare paid $6,067.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 27 | 26 | $44.29 | $1,196 |
| 99214 Office E&M - Established | Facility | 16 | 13 | $69.09 | $1,106 |
| 99203 Office E&M - New | Facility | 14 | 14 | $58.34 | $817 |
| 99204 Office E&M - New | Facility | 13 | 13 | $79.73 | $1,036 |
By year: 2022 $8,800 for 402 services; 2023 $14K for 608 services; 2024 $6,067 for 276 services.
Medicare prescription drug claims, 2024
In 2024, the drug Taha Al-Shaikhly prescribed most often to Medicare patients was Fluticasone Propionate, with 79 prescriptions and refills. In total Taha Al-Shaikhly wrote 552 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 79 | 103 | 20 | $715 |
| Azelastine Hcl Generic | 61 | 88 | 26 | $1,540 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 45 | 49 | 19 | $969 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 33 | 41 | Under 11 | $7,870 |
| Epinephrine Generic | 33 | 35 | 20 | $5,549 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 32 | 32 | Under 11 | $21K |
| Dupixent Pen Dupilumab | 31 | 31 | Under 11 | $157K |
| Tezspire Tezepelumab-Ekko | 26 | 26 | Under 11 | $116K |
| Nucala Mepolizumab | 22 | 22 | Under 11 | $85K |
| Montelukast Sodium Generic | 21 | 46 | Under 11 | $303 |
| Fluticasone-Salmeterol Hfa Fluticasone Propion/Salmeterol | 15 | 15 | Under 11 | $6,781 |
| Breyna Budesonide/Formoterol Fumarate | 15 | 15 | Under 11 | $2,611 |
| Ipratropium Bromide Generic | 14 | 21 | Under 11 | $505 |
| Spiriva Respimat Tiotropium Bromide | 13 | 14 | Under 11 | $6,507 |
| Breo Ellipta Fluticasone/Vilanterol | 12 | 12 | Under 11 | $4,683 |
Brand drugs: 299 claims; generic drugs: 253 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Taha Al-Shaikhly $19.45 ($19.45 in general payments such as food, travel and fees) from 1 company. The largest payer was Ionis Pharmaceuticals, Inc. with $19.45.
| Company | Payments | Amount |
|---|---|---|
| Ionis Pharmaceuticals, Inc. IONS | 1 | $19.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.